I am increasingly puzzled by this conversation. If you are doing a clinical trial, you have to harmonise all the arms of that trial for it to be randomly and properly assessed and for its statistics to be valid. Is the noble Baroness suggesting that we do our own small trials, irrespective of what is going on in a much larger pool of people? Does she not understand that, given the genetic diversity of the European population, the more people who are involved in the same trial, the more relevant the answers to the trial are, particularly in cases such as cancer, where they are all under the same rules?
European Union (Withdrawal) Bill
Proceeding contribution from
Lord Winston
(Labour)
in the House of Lords on Monday, 12 March 2018.
It occurred during Committee of the Whole House (HL)
and
Debate on bills on European Union (Withdrawal) Bill.
About this proceeding contribution
Reference
789 c1339 Session
2017-19Chamber / Committee
House of Lords chamberLibrarians' tools
Timestamp
2018-03-13 12:43:49 +0000
URI
http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000133
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000133
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000133